Cargando…

Post-COVID syndrome: Turning convalescence into illness? – Authors’ reply

Detalles Bibliográficos
Autores principales:	Augustin, Max, Lehmann, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275030/ https://www.ncbi.nlm.nih.gov/pubmed/34308410 http://dx.doi.org/10.1016/j.lanepe.2021.100170

Ejemplares similares

Post-COVID syndrome: Turning convalescence into illness?
por: Cozzi, Giorgio, et al.
Publicado: (2021)

Integral management of COVID-19 in Madrid: Turning things around during the second wave—Authors' reply
por: Candel, Francisco Javier, et al.
Publicado: (2021)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Authors' reply
por: Sipahioglu, Serkan
Publicado: (2016)

Rethinking the role of COVID-19 convalescent plasma in the critically ill
por: Casadevall, Arturo, et al.
Publicado: (2023)

Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
por: Augustin, Max, et al.
Publicado: (2023)

Intestinal Microbiome and Atherosclerosis – Authors' Reply
por: Chen, Lin, et al.
Publicado: (2016)

Alcohol and steatosis: The Japanese paradox — Authors' reply()
por: Roerecke, Michael, et al.
Publicado: (2016)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

Situating Language in the Real-World: Authors’ Reply to Commentaries
por: Murgiano, Margherita, et al.
Publicado: (2021)

Alcohol Dependence and Mortality: Implications for Treatment — Authors' Reply
por: Laramée, Philippe, et al.
Publicado: (2015)

Inhibiting Myopia by (Nearly) Invisible Light? - Author's Reply
por: Tsubota, Kazuo
Publicado: (2017)

New Research Routes to Fight Myopia — Author's Reply
por: Tsubota, Kazuo
Publicado: (2017)

Commentary: A Comment on Qi et al.—Authors’ Reply
por: Qi, X. Sharon, et al.
Publicado: (2012)

“Authors’ Reply: Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection”
por: Sood, Mangla, et al.
Publicado: (2021)

Study of critically ill patients with COVID-19 in New York City – Authors' reply
por: Cummings, Matthew J, et al.
Publicado: (2020)

Author`s Reply
por: Jud, Fabian Nicolas, et al.
Publicado: (2019)

Commentary: ‘Plumbing Leaks: The post-pandemic Neoliberal turn of Tertiary Students’
por: Olsen-Reeder, Vini
Publicado: (2022)

Is a single COVID-19 vaccine dose enough in convalescents ?
por: Focosi, Daniele, et al.
Publicado: (2021)

Towards characterized convalescent plasma for COVID-19: The dose matters
por: Verkerke, Hans P., et al.
Publicado: (2020)

Long-term Healthcare of People with Disorders of Sex Development: Predictors of Pubertal Outcomes of Partial Androgen Insensitivity Syndrome – Authors' Reply
por: Lek, Ngee, et al.
Publicado: (2018)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Reply to ‘Use of convalescent plasma in the treatment of COVID-19’
por: Murakami, Naoka, et al.
Publicado: (2023)

'Post-COVID-19 chronic symptoms' – Author's reply
por: Davido, Benjamin, et al.
Publicado: (2021)

Time for integrating clinical, lifestyle and molecular data to predict drug responses — Authors' reply
por: Pottegård, Anton, et al.
Publicado: (2016)

Cochrane corner: convalescent plasma or hyperimmune immunoglobulin for people with COVID-19
por: Nnaji, Chukwudi Arnest, et al.
Publicado: (2020)

COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic
por: Pirofski, Liise-anne
Publicado: (2023)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
por: Sullivan, David, et al.
Publicado: (2023)

Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author’s reply on commentary
por: Köse, Nuri, et al.
Publicado: (2021)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

The clinical potential of IL-12/IL-35 in treating chemotherapy drug-induced cardiac injury – Authors' reply
por: Ye, Jing, et al.
Publicado: (2018)

Immunization recommendations against hepatitis A in Spain: Effectiveness of immunization in MSM and selection of antigenic variants – Authors' Reply
por: Pintó, Rosa M., et al.
Publicado: (2019)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Turning on Natural Killer Cells
por: Lanier, Lewis L.
Publicado: (2000)

Community‐based decentralized mental health services are essential to prevent the epidemic turn of post‐Covid mental disorders in Bangladesh: A call to action
por: Islam, Md. Rabiul, et al.
Publicado: (2022)

The mystery of the COVID toes – turning evidence-based medicine on its head
por: Bristow, Ivan R., et al.
Publicado: (2020)

Reply
por: Tamura, Kiyoshi
Publicado: (2023)

Turning dyneins off bends cilia
por: King, Stephen M.
Publicado: (2018)

Another trial for the TARGET trial. Author’s reply
por: Hagel, Stefan, et al.
Publicado: (2022)

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8opv9n4ib6v3k6ovpqc9u7ej1g